MS and MG

Multiple Sclerosis and Myasthenia Gravis

What is Multiple Sclerosis?

  • Definition: Chronic, progressive, degenerative disorder affecting the central nervous system (CNS).

  • Pathophysiology: Characterized by demyelination of nerve fibers in the brain and spinal cord.

  • Onset: Typically occurs between the ages of 20 to 40.

  • Gender Prevalence: More common in women, with a likelihood of 2-3 times higher than men.

Characteristics of Multiple Sclerosis

  • Disease Pattern: Exhibits a remission and exacerbation pattern.

  • Disability Potential: Considered potentially disabling due to its effects on the brain and spinal cord.

  • Variability: Highly variable pace of progression; many atypical forms are observed.

Pathophysiology of MS

  • Autoimmunity: Activation of T-cells causing CNS inflammation.

  • Demyelination: Slows nerve impulses, affecting communication within the CNS.

  • Gliosis: Leads to plaque formation.

  • Late Disease Impact: Results in irreversible axon damage.

Clinical Manifestations of MS

  • General Symptoms: Fatigue, weakness, numbness, pain.

  • Visual Symptoms: Issues such as diplopia and nystagmus.

  • Neurological Signs: Lhermitte's sign (electric shock-like sensations upon neck flexion), speech/swallowing difficulties, spasticity.

  • Functional Impairments: Bowel/bladder dysfunction and sexual dysfunction.

Specific Symptoms of Multiple Sclerosis

  • Sensory Symptom Percentages:
      - Fatigue: 54%
      - Cognitive problems: (memory loss, personality changes): percentages as follows:
        - Spasticity: 31%
        - Intention tremors: 16%
        - Visual loss: 9%
        - Diplopia: 7%
        - Gait disturbance: data on prevalence not provided.
      - Balance problems: % not specified
      - Lhermitte sign: 9% (based on context, inferred)
      - Other Symptoms Include: Vertigo, bladder problems, limb ataxia, acute transverse myelopathy, and various levels of pain.

Detailed Clinical Examples of Symptoms

  • Visual Symptoms: Nystagmus, diplopia, blurred vision.

  • Speech Impairments: Dysarthria, dysphagia (difficulty swallowing).

  • CNS Effects: Cognitive impairment, depression, unstable mood.

  • Sensation: Pain and paresthesias; Lhermitte's sign; dizziness.

  • Urinary Symptoms: Incontinence, frequency, or retention issues.

  • Musculoskeletal Symptoms: Weakness, spasms, tremors, and ataxia.

  • Bowel Symptoms: Diarrhea or constipation.

  • Reproductive Symptoms: Erectile dysfunction, decreased libido, decreased sensation.

Types of Multiple Sclerosis

  • Relapsing-remitting MS: Accounts for 85% of cases.

  • Primary-progressive MS: Comprises 10% of cases.

  • Secondary-progressive MS: Involves a change from relapsing-remitting to progressive form.

  • Progressive-relapsing MS: Represents 5% of cases.

Diagnostic Studies for MS

  • Initial Assessment: Comprehensive medical history and in-depth neurological exam focusing on gait, posture, coordination, and balance.

  • MRI: Test of choice for supporting a clinical diagnosis by revealing MS lesions.

  • Evoked Potential Tests: Measure electrical signals sent to the brain in response to stimuli using either visual or electrical stimuli.

  • Lumbar Puncture: Helps identify increased WBCs or proteins while ruling out viral infections.

Diagnosis of Multiple Sclerosis

  • A confirmed diagnosis requires evidence of one of the following patterns:
      - Two or more episodes of exacerbation occurring at least one month apart, lasting more than 24 hours, with recovery.
      - Clinical history showing clearly defined exacerbations and remissions, followed by progressive symptoms over at least six months.
      - Slow and stepwise progression of signs and symptoms over a minimum of five months.

Treatment of Multiple Sclerosis

  • Treatment Strategy: Highly individualized care plan.

  • Goals of Drug Therapy:
      - Modify the disease process.
      - Treat acute exacerbations.
      - Manage symptoms effectively.

Nonpharmacologic Interventions for MS

  • Physical and Occupational Therapy: Includes strengthening exercises and adaptations for daily tasks; mobility assistance provided by canes, wheelchairs, or scooters.

  • Counseling: Aims to provide coping strategies for patients and their families.

Key Self-Management Strategies in MS

  • Self-Care Education: Teach recognizing personal triggers (e.g., infection, trauma, stress).

  • Rest: A crucial strategy to help combat fatigue.

  • Exercise: Regular aerobic exercises aid in improving strength, muscle tone, balance, coordination, and managing depression; swimming is recommended.

  • Environmental Control: Recommendations include avoiding extreme heat, utilizing air conditioning, or taking cool baths.

  • Nutrition: Emphasis on a well-balanced diet to support overall health.

Coping Skills for Living with MS

  • Daily Activities: Encouraging maintenance of normal daily activities as much as possible.

  • Social Connections: The importance of staying connected with friends and family and continuing hobbies.

  • Support Groups: Encouragement to join support groups for sharing experiences and feelings.

  • Physical Health: Maintaining physical health is deemed crucial for overall mental well-being.

Nursing Care Considerations for MS

  • Fatigue Management: Include energy conservation techniques and methods for managing fatigue.

  • Fall Prevention and Home Safety: Important protocols to avoid accidents.

  • Promotion of Exercise and Physical Therapy: To maintain mobility and strength.

  • Complications Care: Prevention strategies during exacerbation phases.

  • Emotional Support and Education: Provide psychological support along with educational resources.

Myasthenia Gravis

What is Myasthenia Gravis?

  • Definition: Translates to “grave muscle weakness,” an autoimmune disease affecting the neuromuscular junction.

  • Mechanism: Antibodies destroy acetylcholine (ACh) receptors, leading to skeletal muscle weakness exacerbating with use throughout the day.

  • Affected Areas: Initially affects facial, neck, and jaw muscles, with arm and leg muscle involvement appearing later.

Characteristics of Myasthenia Gravis

  • Symptoms Variation: Patients experience remissions and exacerbations.

  • Triggers: Flares associated with emotional stress, pregnancy, illness, or extreme heat.

  • Severity: Varies widely from mild disturbances to potential respiratory failure.

  • Types: Two main types: Ocular (affecting eye muscles) and generalized; approximately half of patients present with visual problems.

Clinical Manifestations of Myasthenia Gravis

  • Common Symptoms Include:
      - Ocular Symptoms: Ptosis (drooping eyelids) and diplopia.
      - Bulbar Symptoms: Difficulties with chewing, swallowing, and speech.
      - Motor Symptoms: Proximal limb weakness that is aggravated in the evening and improves with rest.

  • Abnormalities: Not typically associated with atrophy or reflex loss.

Diagnosis of Myasthenia Gravis

  • Diagnostic Methodologies: Depends on ocular versus generalized symptoms.
      - Bedside Tests: Simple tests are performed but can yield false positives, most effective in patients with ptosis where seen improvements can be assessed.
      - Tensilon (Edrophonium) Test: An acetylcholinesterase inhibitor given intravenously, showcases symptom improvement in MG within 30 to 45 seconds and lasts for 5 to 10 minutes.
      - Ice Pack Test: Utilizes reduced temperatures to improve neuromuscular transmission; applied ice pack on the eyelid for 2 minutes, followed by immediate assessment of ptosis improvement.

Advanced Diagnostic Techniques for Myasthenia Gravis

  • Serologic Tests: Detect autoantibodies including Acetylcholine receptor antibodies (AChR-Ab) and Muscle-specific kinase antibodies (MuSK).

  • Electrophysiological Studies:
      - Repetitive Nerve Stimulation (RNS) Study: Most frequently used electrodiagnostic test for MG, detects decline in response amplitude in affected nerves upon stimulation.
      - Single-fiber Electromyography (EMG): A sensitive diagnostic tool, though technically demanding and less available.

Collaborative Care for Myasthenia Gravis

  • Short-Term Treatments: Utilized until other medications become effective or prior to surgical intervention.
      - 1. Intravenous Immunoglobulin (IVIG): Delivery of immunoglobulin that suppresses the immune system's production of antibodies.
      - 2. Plasmapheresis: A plasma exchange procedure designed to remove antibodies; involves 6 exchanges spread over two weeks with additional follow-ups as necessary.

Surgical Management for Myasthenia Gravis

  • Thymectomy: Surgical removal of the thymus gland; this procedure is performed early in the diagnosis (ideally within 2 years of symptom onset) as the thymus is known to enhance AChR antibody production.

Nursing Management of Myasthenia Gravis

  • Monitoring: Close observation of respiratory status, speech, and swallowing abilities in patients.

  • Medication Timing: Coordinate medications to ensure peak effects during meals.

  • Dietary Recommendations: Encourage small, frequent meals with semisolid foods for easier digestion.

  • Energy Conservation: Promote low-exertion activities to prevent fatigue and complications.

Patient Education for Myasthenia Gravis

  • Understanding Triggers: Educate on potential flare causes and medication schedules.

  • Complications Awareness: Discuss complications related to disease and therapy, including crisis states.

  • Support Resources: Encourage participation in support groups for additional social and emotional support.

Myasthenic vs. Cholinergic Crisis

  • Myasthenic Crisis: Resulting from inadequate dosing of anticholinesterase drugs or infection.
      - Unique Features: Increased vital signs, bowel/bladder incontinence, absentee cough/swallow reflex, and symptom improvement upon Tensilon testing.

  • Cholinergic Crisis: Resulting from excessive anticholinesterase drugs.
      - Unique Features: Flaccid paralysis, secretions (saliva, sweat, tears), gastrointestinal symptoms (nausea, vomiting, diarrhea), worsening symptoms upon Tensilon testing.